Study to Evaluate Chronic Myeloid Leukemia Treatment Landscape and Real-life Treatment Outcomes in Hungary: Analysis of National Health Insurance Fund Database

NCT05286528 · clinicaltrials.gov ↗

COMPLETED

Status

1484

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Myeloid Leukaemia

Interventions

DRUG: Bosutinib
DRUG: Imatinib
DRUG: Nilotinib
DRUG: Dasatinib
DRUG: Ponatinib

Sponsor

Pfizer